FDA updates Vizamyl label to improve Alzheimer’s diagnosis, therapy monitoring, and dementia risk prediction, enabling more precise, timely patient care.

GE HealthCare’s PET/CT, SPECT/CT, and Flyrcado enhance cardiac diagnostics with advanced molecular imaging, offering deeper biological insights than traditional methods.

The company debuts AI-powered LesionID Pro and imaging systems to streamline theranostics, enabling faster, personalized cancer diagnosis and treatment monitoring.

GE HealthCare and Stanford Medicine will explore total body PET/CT technology to improve patient outcomes, supporting personalized medicine and healthcare efficiency.

bkActiv S series advances precision care with scalable technology and high-quality imaging for a wide range of applications.

Now with GE HealthCare features and algorithms, MIM Encore streamlines workflows, enhances cross-departmental communication, and reduces manual workloads for excellent PET and SPECT imaging.

New NCCN guidelines support GE Healthcare’s FES PET imaging to improve diagnosis and treatment planning for invasive lobular breast cancer.

Enterprise Imaging solutions are designed to help improve workflow and productivity, enabling better patient care.

GE HealthCare's CleaRecon DL uses AI to enhance CBCT image quality by reducing streaks, aiming to boost diagnostic confidence and support minimally invasive procedures.

Fetal pulse oximetry technology aims to provide real-time insights to clinicians during labor and delivery and improve the detection of fetal distress.